Tuberculosis: a comprehensive international approach
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Dekker
2000
|
| Ausgabe: | 2. ed., rev. and expanded |
| Schriftenreihe: | Lung biology in health and disease
144 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturangaben |
| Beschreibung: | XXVIII, 898 S. Ill., graph. Darst. |
| ISBN: | 082478121X |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV013197954 | ||
| 003 | DE-604 | ||
| 005 | 20000928 | ||
| 007 | t | ||
| 008 | 000608s2000 ad|| |||| 00||| eng d | ||
| 020 | |a 082478121X |9 0-8247-8121-X | ||
| 035 | |a (OCoLC)43441686 | ||
| 035 | |a (DE-599)BVBBV013197954 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 | ||
| 050 | 0 | |a RC311 | |
| 082 | 0 | |a 616.9/95 |2 21 | |
| 084 | |a YE 1500 |0 (DE-625)153369:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Tuberculosis |b a comprehensive international approach |c ed. by Lee B. Reichman ... |
| 250 | |a 2. ed., rev. and expanded | ||
| 264 | 1 | |a New York [u.a.] |b Dekker |c 2000 | |
| 300 | |a XXVIII, 898 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Lung biology in health and disease |v 144 | |
| 500 | |a Literaturangaben | ||
| 650 | 4 | |a Tuberculose | |
| 650 | 4 | |a Tuberculosis | |
| 650 | 0 | 7 | |a Tuberkulose |0 (DE-588)4130621-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Tuberkulose |0 (DE-588)4130621-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Reichman, Lee B. |e Sonstige |4 oth | |
| 830 | 0 | |a Lung biology in health and disease |v 144 |w (DE-604)BV000008326 |9 144 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008991359&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008991359 | ||
Datensatz im Suchindex
| _version_ | 1804127897419513856 |
|---|---|
| adam_text | CONTENTS
Introduction Claude Lenfant v
Preface to the Second Edition vii
Preface to the First Edition ix
Contributors xi
Part One PROGRAMMATIC BACKGROUND
1. A Historical Perspective on Tuberculosis and Its Control 3
Anne L. Davis
I. Early Perceptions and Practices 5
II. Concepts from the Renaissance Through the Eighteenth
Century 7
III. Nineteenth and Twentieth Century Developments
and Concepts 10
References 43
2. Tuberculosis Control in Low Income Countries 55
Donald A. Enarson
I. Introduction 55
II. Objectives of Tuberculosis Control 55
III. The Scientific Basis of Intervention 56
IV. Prevention Through Treatment 57
V. Basic Principles of Tuberculosis Control 58
VI. Adaptations for Low Income Countries 60
VII. Achieving Success in Low Income Countries 62
VIII. Effective Strategies for the Management of Tuberculosis 65
xvii
xviii Contents
IX. Future Challenges 68
References 11
3. Tuberculosis Control in Low Prevalence Countries 75
Jaap F. Broekmans
I. The Prospect of Elimination 75
II. Framework for Tuberculosis Control in Low Prevalence
Countries 81
III. Surveillance 86
IV. Program Monitoring 89
References 92
4. Tuberculosis Laboratories: The Centerpiece of National
Tuberculosis Control Programs 95
Adalbert Laszlo
I. Introduction 95
II. National Tuberculosis Programs 97
III. Tuberculosis Diagnostic Services 99
IV. Tuberculosis Diagnostic Techniques 100
V. The NTP National Tuberculosis Laboratory Network 101
VI. Structure and Function of the National Tuberculosis
Laboratory Network 101
VII. The National Tuberculosis Laboratory Network as a
Source of Data 103
VIII. The National Tuberculosis Laboratory Network as a Source
of Operational and Epidemiological Information 104
IX. Conclusion 104
References 105
5. Evaluation of Applied Strategies of Tuberculosis Control in the
Developing World 107
Pierre Chaulet and Earl S. Hershfield
I. Introduction 107
II. Prerequisites for Evaluating a Tuberculosis Control
Strategy 108
III. Evaluation of the Strategies Applied in Tuberculosis
Treatment 111
IV. Evaluation of Strategies Applied in the Detection of
Tuberculosis Cases 119
V. Conclusion 124
References 124
Contents xix
Part Two BASIC ASPECTS
6. Epidemiology of Tuberculosis 129
George W. Comstock
I. Introduction 129
II. Etiological Epidemiology 130
HI. Administrative Epidemiology 141
IV. Conclusion 149
References 149
7. Bacteriology of Tuberculosis 157
Jacques Grosset, Chantal Tmffot Pernot, and Emmanuelle Cambau
I. Introduction 157
II. Biological Safety 158
III. General Characteristics of Tubercle Bacilli 158
IV. Bacteriology for Diagnosis and Monitoring Treatment
of Tuberculosis 160
V. Strain Typing of M. tuberculosis 168
VI. Drug Activity Against M. tuberculosis 169
VII. Immunodiagnostic Tests for Tuberculosis 175
VIII. Direct Detection of M. tuberculosis by Nucleic
Acid Amplification 177
References 178
8. Immunology of Tuberculosis 187
Thomas M. Daniel, W. Henry Boom, and Jerrold J. Ellner
I. Introduction 187
II. Mycobacterial Protein Antigens 188
III. The Mycobacterial Cell Wall: Mycobacterial Adjuvants
and Mycobacterial Polysaccharides 192
IV. Granuloma Formation 194
V. Cell Mediated Immunity 194
VI. Humoral Immunity 199
VII. Immune Spectrum and Immunoregulation 200
VIII. HIV M. tuberculosis Interactions 202
IX. Conclusions 203
References 204
9. Transmission of Tuberculosis 215
Edward A. Nardell and Willy F. Piessens
I. Aerobiology of Tuberculosis 217
II. Epidemiology of Transmission 221
xx Contents
III. Infectious Dose for Humans 225
IV. Recent Outbreaks 227
V. Preventing Transmission 228
VI. Governmental Recommendations: An Overview 229
VII. Preventing Transmission from Unsuspected
Cases of Tuberculosis 230
VIII. Engineering Approaches to Preventing Transmission 231
References 236
10. Pathogenesis of Tuberculosis 241
Willy F. Piessens and Edward A. Nardell
I. Introduction 241
II. Stage 1 (Week 1): Invasion 242
III. Stage 2 (Weeks 2 and 3): Logarithmic Bacillary Growth
and the Early Tuberculous Lesion 248
IV. Stage 3 (After Week 3): Infection Control 249
V. Stage 4 (Months to Years Later): Endogenous
Reactivation and Transmission 252
VI. Clinical Correlates of Immune Events in Human
Tuberculosis 254
VII. Conclusion 255
References 255
11. Mycobacterial Strain Genotyping 261
Nancy D. Connell and Barry N. Kreiswirth
I. Introduction 261
II. Methodologies 262
III. Interpreting Genotypes 265
IV. International Applications of Molecular Fingerprinting 267
V. Implications for Basic Research 269
VI. Clinical Applications of Molecular Fingerprinting 270
References 270
Part Three CLINICAL ASPECTS
12. Tuberculin Skin Testing 279
Richard I. Menzies
I. Introduction 279
II. Technical Aspects 280
Contents xxi
III. Simple Cognitive Aspects: False Negative and
False Positive Reactions 285
IV. Complicated Cognitive Aspects: Interpreting
Tuberculin Tests 296
V. Conclusions 310
References 311
13. Case Finding in High and Low Prevalence Countries 323
Hans L. Rieder
I. Introduction 323
II. Sources of Transmission and Other Cases 324
III. Identification of Sources of Transmission 325
IV. Factors Modifying the Choice of Case Finding Methods 331
V. The Role of Case Finding in Tuberculosis Control 332
VI. Conclusions 333
References 334
14. Diagnosis of Tuberculosis 341
Philip A. LoBue, Sharon Perry, and Antonino Catanzaro
I. Introduction 341
II. Medical History and Physical Examination 341
III. Routine Laboratory Tests 343
IV. The Tuberculin Skin Test 343
V. Diagnostic Tests: Pulmonary Disease 343
VI. Extrapulmonary Tuberculosis 351
VII. Pediatric Tuberculosis 356
VIII. Developments in Rapid Diagnosis: Nucleic Acid
Amplification Tests 356
X. Summary 363
References 363
15. Contact Follow Up in High and Low Prevalence Countries 377
Sue C. Etkind and Jaap Veen
I. Introduction 377
II. Definitions 378
HI. Need for Contact Tracing 379
IV. Contact Tracing in Low Prevalence Countries 380
V. Contact Tracing in High Prevalence Countries 389
VI. New Technology: The Role of Restriction Fragment Length
Polymorphism Testing 391
xxii Contents
VII. Challenges and Unanswered Questions 394
VIII. Summary 395
References 396
16. Treatment of Tuberculosis 401
Paula I. Fujiwara, Patricia M. Simone, and Sonal S. Munsiff
I. Introduction 401
II. History of Tuberculosis Treatment in the Chemotherapeutic
Era 402
III. Antituberculosis Medications 405
IV. Standard Antituberculosis Treatment Regimens in the
United States 415
V. Antituberculosis Treatment Regimens in Resource Poor
Countries 418
VI. Methods Used to Diagnose Tuberculosis and Monitor
Treatment 420
VII. Special Clinical Situations 423
VIII. Adherence to Treatment 432
IX. The Future of Treatment 435
References 436
17. Responding to Outbreaks of Multidrug Resistant Tuberculosis:
Introducing DOTS Plus 447
Paul E. Farmer, Jim Yong Kim, Carole D. Mitnick, and
Ralph Timperi
I. Introduction: Strengths and Limitations of DOTS 447
II. What Is DOTS Plus? 453
III. Making DOTS Plus Work: A Case Study 455
IV. Pitfalls in the Planning and Execution of DOTS Plus
Programs 462
V. Conclusions: DOTS Plus, We Can t Afford Not to Try It 466
References 466
18. Treatment of Latent Tuberculosis Infection 471
David L. Cohn and Wafaa M. El Sadr
I. Introduction 471
II. Treatment of Latent Tuberculosis Infection in
Immunocompetent Hosts 472
III. New Regimens for Treatment of Latent Tuberculosis
Infection 481
Contents xxiii
IV. Treatment of Latent Tuberculosis Infection in
HIV Infected Persons 482
V. Treatment of Latent Tuberculosis Infection in Special
Populations 491
VI. Development of Disease Due to Resistant Organisms 492
VII. Recommendations for Treatment of Latent
Tuberculosis Infection 493
VIII. Conclusions and Future Directions 496
References 497
19. BCG Vaccines and Vaccination 503
Paul E. M. Fine
I. Introduction 503
II. Historical Background 503
III. BCG Vaccines 505
IV. Current BCG Policies 505
V. The Protective Efficacy of BCG 508
VI. Protection Against Diseases Other Than Tuberculosis 512
VII. Adverse Reactions 512
VIII. The Impact of BCG Vaccination Programs 513
IX. Improving Upon BCG 514
X. Immediate Prospects for Vaccination Against
Tuberculosis 516
References 518
Part Four SPECIAL PROBLEMS
20. Tuberculosis and Human Immunodeficiency Virus Infection 525
Philip C. Hopewell and Richard E. Chaisson
I. Risk of Tuberculosis in Persons with HIV Infection 525
II. Prevalence of HIV Infection Among Patients
with Tuberculosis 528
III. Influence of HIV Infection on the Pathogenesis
of Tuberculosis 529
IV. Diagnosis of Tuberculosis Infection and Tuberculosis 531
V. Treatment 535
VI. Tuberculosis Caused by Multidrug Resistant Organisms 539
VII. Prevention 541
VIII. Infection Control 544
IX. Influence of Tuberculosis on the Course of HIV Infection 545
xxiv Contents
X. Necessary Changes in Approaches to Tuberculosis
Control 545
References 547
21. Tuberculosis in Children 553
Flor M. Munoz and Jeffrey R. Starke
I. Introduction 553
II. Epidemiology 555
III. Pathogenesis 560
IV. Clinical Forms of Tuberculosis 563
V. Diagnosis of Tuberculosis in Children 574
VI. Treatment 578
References 586
22. Case Management: The Key to a Successful
Tuberculosis Control Program 597
Bonita T. Mangura and Karen E. Galanowsky
I. Introduction 597
II. Directly Observed Therapy 598
III. Clinical Care and Public Health 598
IV. The Newark Experience 599
V. The Nurse Case Management Model 600
VI. Tuberculosis Therapy by Directly Observed Therapy 601
VII. Incremental Service Delivery Change and DOT 602
VIII. The Interaction: Patient and Health Care Provider 604
IX. Impact on TB Control 604
References 605
Part Five UNIQUE ASPECTS OF TUBERCULOSIS CONTROL
23. Tuberculosis Infection Control 609
Henry M. Blumberg
I. Introduction and Historical Overview 609
II. Trends in Nosocomial Transmission of Tuberculosis 610
HI. Institutional Controls in the United States and Other
Developed Countries 617
IV. Hospital Discharge Planning and Standards 630
V. OSHA Requirements for a Tuberculosis Control Program 631
VI. Institutional Controls in Developing Countries and Areas
with Very Limited Resources 631
References 636
Contents xxv
24. Tuberculosis in Correctional Facilities 645
Naomi N. Bock
I. Introduction 645
II. Epidemiology of Tuberculosis in Correctional Facilities 646
III. Transmission of Tuberculosis in Correctional Facilities 648
IV. Risk Factors for Tuberculosis Among Inmates in
Correctional Facilities 648
V. Correctional Facility Tuberculosis and the Community
at Large 649
VI. Controlling Tuberculosis in Correctional Facilities 651
References 654
25. Tuberculosis Among Immigrants 661
Mona Saraiya and Nancy J. Binkin
I. Introduction 661
II. History of Migration of TB 661
III. Definitions 662
IV. Epidemiology of TB Among Foreign Born Persons 664
V. Drug Resistance 675
VI. Contribution of Immigration to Transmission of TB in
Low Prevalence Countries 677
VII. Approaches to TB in the Foreign Born 678
References 687
26. Coalition Building for Tuberculosis Control: The Philippine
Experience 693
Camilo C. Roa, Jr., and Rodrigo L. C. Romulo
I. Coordinating Tuberculosis Control Efforts: The Need
for Coalitions 693
II. TB Interest Groups 694
III. Rallying Around a Common Goal 696
IV. The Philippine Coalition Against Tuberculosis 696
V. Formalizing and Expanding 697
VI. Generating Resources 697
VII. The Birth of PHILCAT 698
VIII. Pushing Onwards 698
IX. Developing a Unified Strategy: Identifying More
Stakeholders 700
X. National Consensus on Tuberculosis 702
XI. Coalition Activities: Achieve Objectives and Maintain
Member Enthusiasm 702
xxvi Contents
XII. Summary 703
References 703
27. Tuberculosis Education 705
Eileen C. Napolitano and Elizabeth J. Stoller
I. Introduction 705
II. Evidence of the Need for Training and Education for
Providers 707
III. Current Training Initiatives 711
IV. Health Care Providers in Need of Education and Training 713
V. Methods 714
VI. Future Directions for Training 717
VII. Topics for Further Discussion 718
References 720
28. Political Will: The Singapore Tuberculosis Elimination
Program 727
Cynthia Bin Eng Chee and Yee Tang Wang
I. Singapore: An Island City State 727
II. Tuberculosis in Singapore 729
HI. Rationale for the Singapore Tuberculosis Elimination
Program 734
IV. Organizational Structure of STEP 735
V. Key Factors for the Success of STEP 736
VI. Conclusion 739
References 740
29. Medical Anthropology: An Important Adjunct to International
TB Control 745
Daniel Chemtob, Sheri Weiser, Israel Yitzhak, and
Daniel Weiler Ravell
I. Introduction 745
II. The Relevance of Social Science to Public Health 746
III. Some Basic Concepts in Social Science 750
IV. Some Key Perspectives in the Social Science Literature
on TB 754
V. An Anthropological Study of TB Among Ethiopian
Immigrants in Israel 757
VI. The Contribution of Social Science to the New National
Program for the Elimination of TB in Israel 762
VII. Conclusion 765
References 766
Contents xxvii
30. The Role of Nongovernmental Organizations 771
Annik Rouillon, Nils Eric Billo, and Frances R. Ogasawara
I. Introduction 771
II. National Tuberculosis Associations 775
III. The International Union Against Tuberculosis and
Lung Disease 787
IV. Present Trends: Irreplaceable Partners 793
V. Summary 795
References 795
31. Economic Considerations for Tuberculosis Control 799
Holger Sawert
I. Political Commitment and Economic Arguments 799
II. Economic Analysis: Basic Concepts 802
HI. Specific Points for the Analysis of Tuberculosis Control
Interventions 804
IV. Example: Improving Tuberculosis Control in Thailand 807
References 814
32. The Impact of Managed Care on Tuberculosis Control in the
United States 817
Bess Miller and Sara Rosenbaum
I. Introduction 817
II. Tuberculosis Control in the United States: Current
Organizational Structure 818
III. The Advent of Managed Care and Its Impact on
TB Control 819
IV. Concerns of TB Health Officials About Managed Care 820
V. Response of TB Health Officials to the Advent of
Managed Care 821
VI. Role of Contracts and Memoranda of Agreement 823
VII. Conclusion 825
References 825
33. The Impact of Health Sector Reform on Tuberculosis Control
in Developing Nations 829
Elizabeth Tayler
I. Introduction 829
II. Why Health Sector Reform Is Needed 831
III. Impact of Health Sector Reform Upon TB Services 832
IV. Political Commitment 833
xxviii Contents
V. Case Finding and Diagnosis 834
VI. Standardized Short Course Regimen and Supervision of
Therapy 835
VII. Drug Supply 837
VIII. Recording and Reporting 837
IX. Conclusions 838
References 840
34. Mobilizing Society Against Tuberculosis: Creating and
Sustaining Demand for DOTS in High Burden Countries 843
Kraig Klaudt
I. Assessment of the Current Response to the Global TB
Epidemic 843
II. The Role of Information, Education, and Communication,
Advocacy, and Social Mobilization 846
III. The C.A.U.S.E. Strategy for Mobilizing Society 850
IV. The Main Components of Advocacy 854
V. Potential Initiatives to Help Mobilize Society to
Control TB 858
VI. Conclusion 863
References 863
Part Six THE FUTURE
35. Tuberculosis in the Future 867
Richard J. O Brien and Mario C. Raviglione
I. Tuberculosis in the 1990s: Reasons to Be Hopeful 867
II. Problems Looming at the End of the Twentieth Century 871
III. TB in the New Millennium: Clues from Modelers 874
IV. The Promise of New Technologies 877
V. Tuberculosis Elimination: An Impossible Dream? 878
References 881
Index 885
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV013197954 |
| callnumber-first | R - Medicine |
| callnumber-label | RC311 |
| callnumber-raw | RC311 |
| callnumber-search | RC311 |
| callnumber-sort | RC 3311 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YE 1500 |
| ctrlnum | (OCoLC)43441686 (DE-599)BVBBV013197954 |
| dewey-full | 616.9/95 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9/95 |
| dewey-search | 616.9/95 |
| dewey-sort | 3616.9 295 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 2. ed., rev. and expanded |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01502nam a2200409 cb4500</leader><controlfield tag="001">BV013197954</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20000928 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">000608s2000 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">082478121X</subfield><subfield code="9">0-8247-8121-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)43441686</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013197954</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC311</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9/95</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YE 1500</subfield><subfield code="0">(DE-625)153369:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tuberculosis</subfield><subfield code="b">a comprehensive international approach</subfield><subfield code="c">ed. by Lee B. Reichman ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2. ed., rev. and expanded</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXVIII, 898 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Lung biology in health and disease</subfield><subfield code="v">144</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tuberculose</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tuberculosis</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tuberkulose</subfield><subfield code="0">(DE-588)4130621-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Tuberkulose</subfield><subfield code="0">(DE-588)4130621-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reichman, Lee B.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Lung biology in health and disease</subfield><subfield code="v">144</subfield><subfield code="w">(DE-604)BV000008326</subfield><subfield code="9">144</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008991359&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008991359</subfield></datafield></record></collection> |
| id | DE-604.BV013197954 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:40:39Z |
| institution | BVB |
| isbn | 082478121X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008991359 |
| oclc_num | 43441686 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| physical | XXVIII, 898 S. Ill., graph. Darst. |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Dekker |
| record_format | marc |
| series | Lung biology in health and disease |
| series2 | Lung biology in health and disease |
| spelling | Tuberculosis a comprehensive international approach ed. by Lee B. Reichman ... 2. ed., rev. and expanded New York [u.a.] Dekker 2000 XXVIII, 898 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Lung biology in health and disease 144 Literaturangaben Tuberculose Tuberculosis Tuberkulose (DE-588)4130621-1 gnd rswk-swf Tuberkulose (DE-588)4130621-1 s DE-604 Reichman, Lee B. Sonstige oth Lung biology in health and disease 144 (DE-604)BV000008326 144 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008991359&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Tuberculosis a comprehensive international approach Lung biology in health and disease Tuberculose Tuberculosis Tuberkulose (DE-588)4130621-1 gnd |
| subject_GND | (DE-588)4130621-1 |
| title | Tuberculosis a comprehensive international approach |
| title_auth | Tuberculosis a comprehensive international approach |
| title_exact_search | Tuberculosis a comprehensive international approach |
| title_full | Tuberculosis a comprehensive international approach ed. by Lee B. Reichman ... |
| title_fullStr | Tuberculosis a comprehensive international approach ed. by Lee B. Reichman ... |
| title_full_unstemmed | Tuberculosis a comprehensive international approach ed. by Lee B. Reichman ... |
| title_short | Tuberculosis |
| title_sort | tuberculosis a comprehensive international approach |
| title_sub | a comprehensive international approach |
| topic | Tuberculose Tuberculosis Tuberkulose (DE-588)4130621-1 gnd |
| topic_facet | Tuberculose Tuberculosis Tuberkulose |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008991359&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000008326 |
| work_keys_str_mv | AT reichmanleeb tuberculosisacomprehensiveinternationalapproach |